17 results on '"Kaiser T"'
Search Results
2. Revisiting Andrews method and grain boundary resistivity from a computational multiscale perspective
- Author
-
Güzel, D., Kaiser, T., Bishara, H., Dehm, G., and Menzel, A.
- Published
- 2024
- Full Text
- View/download PDF
3. Prevalence of suicidal ideation in German psychotherapy outpatients: A large multicenter assessment
- Author
-
Teismann, T., Forkmann, T., Glaesmer, H., Alpers, G.W., Brakemeier, E.L., Brockmeyer, T., Christiansen, H., Fehm, L., Glombiewski, J., Heider, J., Hermann, A., Hoyer, J., Kaiser, T., Klucken, T., Lincoln, T.M., Lutz, W., Margraf, J., Pedersen, A., Renneberg, B., Rubel, J., Rudolph, A., Schöttke, H., Schwartz, B., Stark, R., Velten, J., Willutzki, U., Wilz, G., and In-Albon, T.
- Published
- 2024
- Full Text
- View/download PDF
4. Anwendungsbegleitende Datenerhebungen für die Nutzenbewertung von Arzneimitteln in Deutschland: Warum, wann und wie?
- Author
-
Kaiser, T, Vervölgy, V, Kaiser, T, and Vervölgy, V
- Abstract
For newly authorised medicinal products with new active substances, a benefit assessment is carried out at the time of their market access in Germany. The subject of this assessment is the question of the additional benefit of the new active substance compared to the current standard therapy (the "appropriate comparator") with regard to patient-relevant outcomes. Orphan drugs (medicinal products for rare diseases) are treated separately. For these, the additional benefit is considered proven with market access, regardless of the actual data. Only with annual sales of at least 30 million euros a regular assessment will be conducted. In this case, data for comparison with an appropriate comparator has to be submitted. An analysis shows that in such regular benefit assessments, an additional benefit cannot be proven for orphan drugs in more than half of the cases. In 2019, in recognition of the often insufficient evidence base for orphan drugs, the "Anwendungsbegleitende Datenerhebung" (AbD: collection of routine practice data) was established as a further component of the benefit assessment. Accordingly, the Federal Joint Committee (G-BA) can demand an AbD for orphan drugs as well as for medicinal products with a conditional marketing authorisation or marketing authorisation under exceptional circumstances. The pharmaceutical company is responsible for conducting the AbD. The AbD has to generate data on the new active substance as well as meaningful data for comparison with the appropriate comparator. The AbD is to be conducted as a study without randomisation, and the G-BA has to determine concrete specifications on the methodology and patient-relevant endpoints.The first step of the AbD is the preparation of a study protocol (SP) and a statistical analysis plan (SAP) under the responsibility of the company. These documents are checked with regard to their content-related and methodological suitability for conducting the AbD including the associated evaluation of the, Für neu zugelassene Arzneimittel mit neuen Wirkstoffen wird zum Zeitpunkt ihres Marktzugangs in Deutschland eine Nutzenbewertung durchgeführt. Gegenstand dieser Nutzenbewertung ist die Frage nach dem Zusatznutzen des neuen Wirkstoffs gegenüber der aktuellen Standardtherapie (der "zweckmäßigen Vergleichstherapie") bezüglich patientenrelevanter Endpunkte. Für Orphan Drugs (Arzneimittel für seltene Erkrankungen) gibt es eine Sonderregel. Für diese gilt der Zusatznutzen mit Marktzugang als belegt, unabhängig von der tatsächlichen Datenlage. Erst bei einem Jahresumsatz von mindestens 30 Mio. Euro wird ein Orphan Drug regulär bewertet, so dass in diesem Fall auch Daten gegenüber der zweckmäßigen Vergleichstherapie vorgelegt werden müssen. Eine Analyse zeigt, dass sich bei solchen regulären Nutzenbewertungen in mehr als der Hälfte der Fälle für Orphan Drugs kein Zusatznutzen nachweisen lässt. Im Jahr 2019 wurde in Kenntnis der oftmals unzureichenden Datenlage die Anwendungsbegleitende Datenerhebung (AbD) als weiterer Baustein der Nutzenbewertung etabliert. Der Gemeinsame Bundesausschuss (G-BA) kann demnach für Orphan Drugs sowie für Arzneimittel mit bedingter Zulassung oder Zulassung unter außergewöhnlichen Umständen eine AbD fordern, für deren Durchführung dann der pharmazeutische Unternehmer zuständig ist. Mit der AbD müssen nicht nur Daten zum neuen Wirkstoff, sondern aussagekräftige Daten zum Vergleich mit der zweckmäßigen Vergleichstherapie generiert werden. Die AbD ist als Studie ohne Randomisierung durchzuführen, und der G-BA hat konkrete Vorgaben zur Methodik und zu patientenrelevanten Endpunkten zu bestimmen.Erster Schritt der AbD ist die Erstellung eines Studienprotokolls (SP) und eines statistischen Analyseplans (SAP) in Verantwortung des pharmazeutischen Unternehmers. Diese Dokumente werden hinsichtlich ihrer inhaltlichen und methodischen Eignung für die Durchführung der AbD einschließlich der zugehörigen Auswertung geprüft. Die Adjustierung für Confounder stel
- Published
- 2024
5. Die geriatrische Frührehabilitation nach hüftgelenknahem Oberschenkelbruch
- Author
-
Lögters, T., Hakimi, M., Linhart, W., Kaiser, T., Briem, D., Rueger, J., and Windolf, J.
- Abstract
Zusammenfassung: Hintergrund: Im Rahmen moderner Versorgungsstrategien von hüftgelenknahen Oberschenkelbrüchen erfolgt meist im Anschluss an die belastungsstabile Versorgung der Fraktur im Akutkrankenhaus eine stationäre interdisziplinär-geriatrische Frührehabilitation. Ob diese Versorgungssysteme einen effektiven Beitrag zur nachhaltigen Versorgungsqualität darstellen oder lediglich zu einer Kostenverschiebung mit Verkürzung der Verweildauer im operierenden Krankenhaus führen, wird kontrovers diskutiert. Patienten und Methodik: Im Rahmen einer prospektiven Studie wurden 282 Patienten mit einer hüftgelenknahen Fraktur und einem Lebensalter von durchschnittlich 86±7,9 Jahren (Range 65–110) eingeschlossen. Alle Patienten wurden operativ versorgt und anschließend nach durchschnittlich 12±9 Tagen (4–103) in eine stationäre geriatrische Rehabilitation verlegt. Die mittlere Rehabilitationsdauer dort betrug 27±13 Tage. Zielparameter der Studie waren die Alltagsaktivität gemessen am Barthel-Index (BI) und die Wohnsituation der Patienten zum Zeitpunkt der Entlassung aus dem Akutkrankenhaus, unmittelbar nach der Rehabilitation und 1 Jahr nach dem Unfallereignis. Des Weiteren wurde der Einfluss definierter patientenbezogener Variablen auf das langfristige Aktivitätsniveau untersucht. Ergebnisse: Bei Entlassung aus dem Akutkrankenhaus lag der BI bei 42±20 Punkten und erhöhte sich auf 65±26 Punkte nach Abschluss der Rehabilitation. Ein Jahr später lag er bei 67±28 Punkten. Während der Rehabilitation verbesserten sich 90% aller Patienten im BI. Innerhalb eines Jahres kam es bei 40% der Patienten wieder zu einer Verschlechterung der Alltagsaktivität. 51% der Patienten konnten in ihr gewohntes Umfeld reintegriert werden. Ein Jahr nach dem Unfallereignis war der BI von Patienten, die nach der Rehabilitation in ihr häusliches Umfeld reintegriert wurden (BI 75±24) signifikant höher als bei Patienten, die bereits vor dem Unfall institutionalisiert waren (BI 52±27). Die Parameter Alter, kognitive Leistungsfähigkeit und Verletzungsart hatten keinen Einfluss auf das langfristige Aktivitätsniveau. Schlussfolgerung: Die geriatrische Frührehabilitation nach einer hüftgelenknahen Fraktur führt kurzfristig bei nahezu allen Patienten zu einer Verbesserung der Versorgungsqualität. Langfristig profitieren vor allem Patienten, die vor dem Unfall zu Hause lebten und auch im Anschluss an die Rehabilitation auf Dauer in ihr häusliches Umfeld reintegriert werden können. Ob jedoch die soziofunktionelle Effektivität stationärer Rehabilitationen die mit steigender Gesamtverweildauer erhöhten Gesamtkosten rechtfertigen, bleibt Gegenstand weiterer gesundheitsökonomischer Untersuchungen.
- Published
- 2024
- Full Text
- View/download PDF
6. Sedierung mit Propofol: Zusätzlicher Nutzen durch eine Ko-Medikation mit Midazolam oder anästhesiologische Überwachung? Eine randomisierte kontrollierte Studie
- Author
-
Franz, H, Kaiser, T, Waltering, A, Heise, T, Reimer, M, and Sawicki, PT
- Published
- 2024
- Full Text
- View/download PDF
7. Dynamische Stabilisierung bei Spinalstenose mit degenerativer Spondylolisthesis
- Author
-
Schaeren, S, Schnake, K, Kaiser, T, and Jeanneret, B
- Published
- 2024
- Full Text
- View/download PDF
8. Increasing outcome measurement precision: Network analysis of items on the Outcome Questionnaire-45.
- Author
-
Kaiser T, Erekson DM, and Ogles BM
- Abstract
Psychotherapy outcome research mainly focuses on scale-level changes and constructs that were developed using cross-sectional statistical analysis, possibly concealing important findings on the level of single items, and limiting the clinical utility of outcome scales. Our goal was to explore changes in symptoms, interpersonal problems, and level of functioning in everyday life and to establish groups of items with similar rates of change that could be used to form more coherent targets for measuring different therapeutic outcomes. Triangulated maximally filtered graphs were used to model the network structure of the Outcome Questionnaire-45 in a data set of N = 12,075 university counseling center patients. Dynamic exploratory graph analysis was used to establish communities of items with similar rates of change. Five item communities (anxiety, hopelessness, interpersonal problems, well-being, and work impairment) were found. Compared to the original Outcome Questionnaire-45 subscales, they showed better fit to the data. The "hopelessness" community, which describes the extent of a patient's demoralization before the start of therapy, had a significantly higher rate of change compared to other communities. The discerned item communities provide clinicians with theoretically grounded, precise targets for outcome tracking, thereby enhancing the responsiveness and adaptability of treatment interventions to individual client trajectories. Such granularity enriches our understanding of therapeutic change, with direct implications for tailoring intervention strategies to maximize early therapeutic gains and sustain long-term recovery. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
- Published
- 2024
- Full Text
- View/download PDF
9. Cell sorting based on pulse shapes from angle resolved detection of scattered light.
- Author
-
Kage D, Eirich A, Heinrich K, Kirsch J, Popien J, Wolf A, Volkmann KV, Chang HD, and Kaiser T
- Subjects
- Humans, Cell Separation methods, Scattering, Radiation, B-Lymphocytes metabolism, Flow Cytometry methods, Light
- Abstract
Flow cytometry is a key technology for the analysis and sorting of cells or particles at high throughput. Conventional and current flow cytometry is primarily based on fluorescent stains to detect the cells of interest. However, such stains also have disadvantages, as their effect on cells must be carefully tested to avoid effects on the results of the experiments. Alternative approaches using imaging or other label-free techniques often require highly sophisticated setups, are commonly limited in resolution, and produce challenging amounts of data. Our technology exploits scattered light instead. The custom-built flow cytometry setup comprises a fiber array in forward scatter detection for angular resolution and captures the whole pulse shape with advanced signal processing. Thereby this setup enables cell analysis and sorting purely based on scattered light signals without the need for fluorescent labels. We demonstrate the feasibility of this cell sorting technology by sorting cell lines for their cell cycle stages based on scattered light. Furthermore, we demonstrate the ability to classify human peripheral blood T- and B-cell subsets., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
10. Is personalization of psychological pain treatments necessary? Evidence from a Bayesian variance ratio meta-analysis.
- Author
-
Scholten S, Herzog P, Glombiewski JA, and Kaiser T
- Abstract
Abstract: This is the first study to empirically determine the potential for data-driven personalization in the context of chronic primary pain (CPP). Effect sizes of psychological treatments for individuals with CPP are small to moderate on average. Aiming for better treatment outcomes for the individual patient, the call to personalize CPP treatment increased over time. However, empirical evidence that personalization of psychological treatments can optimize treatment outcomes in CPP is needed. This study seeks to estimate heterogeneity of treatment effect for cognitive behavioral therapy (CBT) as the psychological treatment approach for CPP with the greatest evidence base. For this purpose, a Bayesian variance ratio meta-regression is conducted using updated data from 2 recently published meta-analyses with randomized controlled trials comparing CBT delivered face-to-face to treatment-as-usual or waiting list controls. Heterogeneity in patients with CPP would be reflected by a larger overall variance in the post-treatment score compared with the control group. We found first evidence for an individual treatment effect in CBT compared with the control group. The estimate for the intercept was 0.06, indicating a 6% higher variance of end point values in the intervention groups. However, this result warrants careful consideration. Further research is needed to shed light on the heterogeneity of psychological treatment studies and thus to uncover the full potential of data-driven personalized psychotherapy for patients with CPP.A Bayesian variance ratio meta-regression indicates empirical evidence that data-driven personalized psychotherapy for patients with chronic primary pain could increase effects of cognitive behavioral therapy., (Copyright © 2024 International Association for the Study of Pain.)
- Published
- 2024
- Full Text
- View/download PDF
11. Transgenic Targeting of Fcrls Creates a Highly Efficient Constitutively Active Microglia Cre Line with Differentiated Specificity.
- Author
-
Kaiser T, Dattero J, Li L, Chen M, Jiang M, Harrahill A, Butovsky O, and Feng G
- Subjects
- Animals, Female, Male, Mice, Brain metabolism, Cell Differentiation physiology, Macrophages metabolism, Mice, Inbred C57BL, Receptors, Cell Surface genetics, Receptors, Cell Surface metabolism, Integrases genetics, Mice, Transgenic, Microglia metabolism
- Abstract
Microglia carry out important functions as the resident macrophages of the brain. To study their role in health and disease, the research community needs tools to genetically modify them with maximum completeness in a manner that distinguishes them from closely related cell types, such as monocytes. While currently available tamoxifen-inducible CreERT2 lines can achieve the differentiation from other cells, the field needs improved and publicly available constitutively active Cre lines, especially ones with favorable efficiency and specificity profiles for studies where high recombination efficiency is imperative and where tamoxifen administration is contraindicated. Here, we leverage the microglia-specific Fcrls gene to generate mice expressing Cre. Using genomic methods, we show correct positioning of the transgene and intact microglia homeostasis in Fcrls-2A-Cre mice. Crossing Fcrls-2A-Cre mice to four different reporters, we demonstrate highly efficient recombination in microglia across differentially sensitive loxP alleles in different genomic contexts, indicating robust applicability of the line. Further, we show that microglia recombine a loxP reporter during early embryonic development, supporting the use of the line for developmental studies. Finally, using immunofluorescence and flow cytometry, we reveal that most border-associated macrophages are also targeted whereas only few liver and spleen macrophages and virtually no white blood cell subsets exhibit Cre activity, distinguishing this line from another publicly available Cre line, Cx3cr1-Cre
M Fcrls-2A-Cre mice are immediately available (JAX #036591) and serve as a valuable addition to the community's microglia toolbox by providing highly efficient constitutive Cre activity with excellent specificity, particularly for studies where tamoxifen administration is undesirable., Competing Interests: The authors declare no competing financial interests., (Copyright © 2024 Kaiser et al.)- Published
- 2024
- Full Text
- View/download PDF
12. Reference intervals and percentiles for soluble transferrin receptor and sTfR/log ferritin index in healthy children and adolescents.
- Author
-
Prenzel F, Kaiser T, Willenberg A, Vom Hove M, Flemming G, Fischer L, Kratzsch J, Kiess W, and Vogel M
- Abstract
Objectives: Soluble transferrin receptor (sTfR) is a marker of both erythropoiesis and iron status and is considered useful for detecting iron deficiency, especially in inflammatory conditions, but reference intervals covering the entire pediatric age spectrum are lacking., Methods: We studied 1,064 (48.5 % female) healthy children of the entire pediatric age spectrum to determine reference values and percentiles for sTfR and the ratio of sTfR to log-ferritin (sTfR-F index) using a standard immunoturbidimetric assay., Results: Soluble TfR levels were highly age-specific, with a peak in infancy and a decline in adulthood, whereas the sTfR-F index was a rather constant parameter. There were positive linear relationships for sTfR with hemoglobin (Hb) (p=0.008) and transferrin (females p<0.001; males p=0.003). A negative association was observed between sTfR and ferritin in females (p<0.0001) and for transferrin saturation and mean corpuscular volume (MCV) in both sexes (both p<0.0001). We found a positive relationship between sTfR and body height, body mass index (BMI) and inflammatory markers (CrP p<0.0001; WBC p=0.0172), while sTfR-F index was not affected by inflammation., Conclusions: Soluble TfR values appear to reflect the activity of infant erythropoiesis and to be modulated by inflammation and iron deficiency even in a healthy cohort., (© 2024 Walter de Gruyter GmbH, Berlin/Boston.)
- Published
- 2024
- Full Text
- View/download PDF
13. Biodegradation kinetics of organic micropollutants in biofilters for advanced wastewater treatment - Impact of operational conditions and biomass origin on removal.
- Author
-
Kaiser T, Fundneider T, and Lackner S
- Abstract
Biofiltration processes are often part of advanced wastewater treatment (aWWT) technologies for the removal of organic micropollutants (OMP) from conventional wastewater treatment plant (WWTP) effluents. Although biological effects are not always the main focus of these technologies (e.g. filtration through granular activated carbon), they have been shown to contribute significantly to total OMP removal. While OMP biodegradation kinetics in conventional biological wastewater treatment are well researched, no systematic comparison to biomass from aWWT is available. This biomass faces different growth conditions and higher OMP concentrations relative to the background organic matter. Adaptation to these conditions could be possible and could lead to faster OMP biodegradation kinetics, which would show in a larger pseudo first-order biodegradation kinetic constant k
biol . In this work, kbiol values for biomass obtained from aWWT biofilters were determined by evaluating OMP removals measured in lab-scale biofilters using a mechanistic model of the experimental setup. A comparison to kbiol values from literature for conventional wastewater treatment (with nutrient removal) revealed similar OMP biodegradation kinetics without any advantages of biomass from aWWT. A conceptual evaluation of influencing factors on OMP removal in biofilters showed that operational parameters (such as the biomass concentration or the empty bed contact time) and the affinity of OMPs to adsorb on biomass have a significant additional effect on biological OMP removal. Therefore, kbiol values alone are not sufficient to estimate biological OMP removal in biofilters and further information about the system is required., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Authors.)- Published
- 2024
- Full Text
- View/download PDF
14. Heterogeneity of Treatment Effects in Internet- and Mobile-Based Interventions for Depression: A Systematic Review and Meta-Analysis.
- Author
-
Terhorst Y, Kaiser T, Brakemeier EL, Moshe I, Philippi P, Cuijpers P, Baumeister H, and Sander LB
- Subjects
- Humans, Internet-Based Intervention, Treatment Outcome, Telemedicine, Mobile Applications, Psychotherapy methods, Adult, Randomized Controlled Trials as Topic, Male, Female, Internet, Treatment Effect Heterogeneity, Depression therapy
- Abstract
Importance: While the effects of internet- and mobile-based interventions (IMIs) for depression have been extensively studied, no systematic evidence is available regarding the heterogeneity of treatment effects (HTEs), indicating to what extent patient-by-treatment interactions exist and personalized treatment models might be necessary., Objective: To investigate the HTEs in IMIs for depression as well as their efficacy and effectiveness., Data Sources: A systematic search in Embase, MEDLINE, Central, and PsycINFO for randomized clinical trials and supplementary reference searches was conducted on October 13, 2019, and updated March 25, 2022. The search string included various terms related to digital psychotherapy, depression, and randomized clinical trials., Study Selection: Titles, abstracts, and full texts were reviewed by 2 independent researchers. Studies of all populations with at least 1 intervention group receiving an IMI for depression and at least 1 control group were eligible, if they assessed depression severity as a primary outcome and followed a randomized clinical trial (RCT) design., Data Extraction and Synthesis: This study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting guidelines. Risk of bias was evaluated using the Cochrane Risk of Bias Tool. HTE was investigated using logarithmic variance ratios (lnVR) and effect sizes using Hedges g. Three-level bayesian meta-regressions were conducted., Main Outcomes and Measures: Heterogeneity of treatment effects was the primary outcome of this study; magnitudes of treatment effect sizes were the secondary outcome. Depression severity was measured by different self-report and clinician-rated scales in the included RCTs., Results: The systematic review of 102 trials included 19 758 participants (mean [SD] age, 39.9 [10.58] years) with moderate depression severity (mean [SD] in Patient Health Questionnaire-9 score, 12.81 [2.93]). No evidence for HTE in IMIs was found (lnVR = -0.02; 95% credible interval [CrI], -0.07 to 0.03). However, HTE was higher in more severe depression levels (β̂ = 0.04; 95% CrI, 0.01 to 0.07). The effect size of IMI was medium (g = -0.56; 95% CrI, -0.46 to -0.66). An interaction effect between guidance and baseline severity was found (β̂ = -0.24, 95% CrI, -0.03 to -0.46)., Conclusions and Relevance: In this systematic review and meta-analysis of RCTs, no evidence for increased patient-by-treatment interaction in IMIs among patients with subthreshold to mild depression was found. Guidance did not increase effect sizes in this subgroup. However, the association of baseline severity with HTE and its interaction with guidance indicates a more sensitive, guided, digital precision approach would benefit individuals with more severe symptoms. Future research in this population is needed to explore personalization strategies and fully exploit the potential of IMI.
- Published
- 2024
- Full Text
- View/download PDF
15. Harmonic FMCW Radar System: Passive Tag Detection and Precise Ranging Estimation.
- Author
-
El-Awamry A, Zheng F, Kaiser T, and Khaliel M
- Abstract
This paper details the design and implementation of a harmonic frequency-modulated continuous-wave (FMCW) radar system, specialized in detecting harmonic tags and achieving precise range estimation. Operating within the 2.4-2.5 GHz frequency range for the forward channel and 4.8-5.0 GHz for the backward channel, this study delves into the various challenges faced during the system's realization. These challenges include selecting appropriate components, calibrating the system, processing signals, and integrating the system components. In addition, we introduce a single-layer passive harmonic tag, developed specifically for assessing the system, and provide an in-depth theoretical analysis and simulation results. Notably, the system is characterized by its low power consumption, making it particularly suitable for short-range applications. The system's efficacy is further validated through experimental evaluations in a real-world indoor environment across multiple tag positions. Our measurements underscore the system's robust ranging accuracy and its ability to mitigate self-interference, showcasing its significant potential for applications in harmonic tag detection and ranging.
- Published
- 2024
- Full Text
- View/download PDF
16. Applying Machine Learning to Blood Count Data Predicts Sepsis with ICU Admission.
- Author
-
Steinbach D, Ahrens PC, Schmidt M, Federbusch M, Heuft L, Lübbert C, Nauck M, Gründling M, Isermann B, Gibb S, and Kaiser T
- Subjects
- Humans, Intensive Care Units, Machine Learning, Hospitalization, Procalcitonin, ROC Curve, Retrospective Studies, Prognosis, Sepsis diagnosis
- Abstract
Background: Timely diagnosis is crucial for sepsis treatment. Current machine learning (ML) models suffer from high complexity and limited applicability. We therefore created an ML model using only complete blood count (CBC) diagnostics., Methods: We collected non-intensive care unit (non-ICU) data from a German tertiary care centre (January 2014 to December 2021). Using patient age, sex, and CBC parameters (haemoglobin, platelets, mean corpuscular volume, white and red blood cells), we trained a boosted random forest, which predicts sepsis with ICU admission. Two external validations were conducted using data from another German tertiary care centre and the Medical Information Mart for Intensive Care IV database (MIMIC-IV). Using the subset of laboratory orders also including procalcitonin (PCT), an analogous model was trained with PCT as an additional feature., Results: After exclusion, 1 381 358 laboratory requests (2016 from sepsis cases) were available. The CBC model shows an area under the receiver operating characteristic (AUROC) of 0.872 (95% CI, 0.857-0.887). External validations show AUROCs of 0.805 (95% CI, 0.787-0.824) for University Medicine Greifswald and 0.845 (95% CI, 0.837-0.852) for MIMIC-IV. The model including PCT revealed a significantly higher AUROC (0.857; 95% CI, 0.836-0.877) than PCT alone (0.790; 95% CI, 0.759-0.821; P < 0.001)., Conclusions: Our results demonstrate that routine CBC results could significantly improve diagnosis of sepsis when combined with ML. The CBC model can facilitate early sepsis prediction in non-ICU patients with high robustness in external validations. Its implementation in clinical decision support systems has strong potential to provide an essential time advantage and increase patient safety., (© Association for Diagnostics & Laboratory Medicine 2024.)
- Published
- 2024
- Full Text
- View/download PDF
17. The use of a kaolin-based hemostatic dressing to attenuate bleeding in dogs: A series of 4 cases.
- Author
-
Huther A, Edwards TH, Jaramillo EL, Giles JT 3rd, Israel SK, Mison M, Ambrosius L, Kaiser T, and Hoareau GL
- Subjects
- Dogs, Humans, Animals, Kaolin therapeutic use, Hemorrhage therapy, Hemorrhage veterinary, Bandages veterinary, Hemostasis, Disease Models, Animal, Hemostatics therapeutic use, Dog Diseases therapy
- Abstract
Objective: To describe the use of a synthetic hemostatic dressing, QuikClot Combat Gauze (QCG), in dogs with bleeding wounds., Case Series Summary: Two dogs presented with bleeding traumatic wounds, and QCG was used to achieve hemostasis during stabilization of these dogs. In the other 2 dogs, QCG was used to help attenuate bleeding associated with a surgical procedure., New or Unique Information Provided: While hemostatic dressings have been widely studied and used in human medicine, there is minimal information on the use and efficacy of these hemostatic dressings in veterinary medicine. This case series describes the use of QCG in dogs with hemorrhaging wounds. QCG could be a valuable resource in veterinary emergency and critical care settings., (© Veterinary Emergency and Critical Care Society 2024.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.